Reposted by Kirit Singh
In glioma, T cell immunotherapies are limited by the quantity of available T cells.
@kiritsingh.bsky.social & team address this challenge in preclinical models by peripheral injection of autologous T cells after pre-treatment with IL-7.
Full report buff.ly/gslmMgl
